These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 29025573)

  • 1. The Nitric Oxide Pathway in Pulmonary Vascular Disease.
    Klinger JR; Kadowitz PJ
    Am J Cardiol; 2017 Oct; 120(8S):S71-S79. PubMed ID: 29025573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The nitric oxide/cGMP signaling pathway in pulmonary hypertension.
    Klinger JR
    Clin Chest Med; 2007 Mar; 28(1):143-67, ix. PubMed ID: 17338933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomarkers in Pulmonary Vascular Disease: Gauging Response to Therapy.
    McMahon TJ; Bryan NS
    Am J Cardiol; 2017 Oct; 120(8S):S89-S95. PubMed ID: 29025575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the nitric oxide-soluble guanylyl cyclase pathway in obstructive airway diseases.
    Dupont LL; Glynos C; Bracke KR; Brouckaert P; Brusselle GG
    Pulm Pharmacol Ther; 2014 Oct; 29(1):1-6. PubMed ID: 25043200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Redox Mechanisms Influencing cGMP Signaling in Pulmonary Vascular Physiology and Pathophysiology.
    Patel D; Lakhkar A; Wolin MS
    Adv Exp Med Biol; 2017; 967():227-240. PubMed ID: 29047089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular nitric oxide: Beyond eNOS.
    Zhao Y; Vanhoutte PM; Leung SW
    J Pharmacol Sci; 2015 Oct; 129(2):83-94. PubMed ID: 26499181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamic association of nitric oxide downstream signaling molecules with endothelial caveolin-1 in rat aorta.
    Linder AE; McCluskey LP; Cole KR; Lanning KM; Webb RC
    J Pharmacol Exp Ther; 2005 Jul; 314(1):9-15. PubMed ID: 15778264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of downstream target genes regulated by the nitric oxide-soluble guanylate cyclase-cyclic guanosine monophosphate signal pathway in pulmonary hypertension.
    Zou L; Xu X; Zhai Z; Yang T; Jin J; Xiao F; Wang C
    J Int Med Res; 2016 Jun; 44(3):508-19. PubMed ID: 27048385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired iNOS-sGC-cGMP signalling contributes to chronic hypoxic and hypercapnic pulmonary hypertension in rat.
    Xia XD; Xu ZJ; Hu XG; Wu CY; Dai YR; Yang L
    Cell Biochem Funct; 2012 Jun; 30(4):279-85. PubMed ID: 22290599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitric oxide/cyclic guanosine monophosphate signaling in the central complex of the grasshopper brain inhibits singing behavior.
    Wenzel B; Kunst M; Günther C; Ganter GK; Lakes-Harlan R; Elsner N; Heinrich R
    J Comp Neurol; 2005 Jul; 488(2):129-39. PubMed ID: 15924338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Escherichia coli lipopolysaccharide downregulates soluble guanylate cyclase in pulmonary artery smooth muscle.
    Scott WS; Nakayama DK
    J Surg Res; 1998 Dec; 80(2):309-14. PubMed ID: 9878330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cellular signalling pathways and pathophysiology of pulmonary arterial hypertension].
    Dao P; Montani D; Duong-Quy S; Dinh-Xuan AT
    Rev Mal Respir; 2006 Feb; 23(1 Suppl):3S75-83. PubMed ID: 16604016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Role of nitric oxide in the control of the pulmonary circulation: physiological, pathophysiological, and therapeutic implications].
    Dias-Junior CA; Cau SB; Tanus-Santos JE
    J Bras Pneumol; 2008 Jun; 34(6):412-9. PubMed ID: 18622509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphodiesterase-5 inhibitors.
    Cockrill BA; Waxman AB
    Handb Exp Pharmacol; 2013; 218():229-55. PubMed ID: 24092343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nitric oxide synthesis leads to vascular endothelial growth factor synthesis via the NO/cyclic guanosine 3',5'-monophosphate (cGMP) pathway in human corpus cavernosal smooth muscle cells.
    Komori K; Tsujimura A; Takao T; Matsuoka Y; Miyagawa Y; Takada S; Nonomura N; Okuyama A
    J Sex Med; 2008 Jul; 5(7):1623-35. PubMed ID: 18331270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances in the pathogenesis and treatment of persistent pulmonary hypertension of the newborn.
    Abman SH
    Neonatology; 2007; 91(4):283-90. PubMed ID: 17575471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitric oxide and cyclic guanosine monophosphate signaling in the eye.
    Murad F
    Can J Ophthalmol; 2008 Jun; 43(3):291-4. PubMed ID: 18443613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble guanylate cyclase-alpha1 deficiency selectively inhibits the pulmonary vasodilator response to nitric oxide and increases the pulmonary vascular remodeling response to chronic hypoxia.
    Vermeersch P; Buys E; Pokreisz P; Marsboom G; Ichinose F; Sips P; Pellens M; Gillijns H; Swinnen M; Graveline A; Collen D; Dewerchin M; Brouckaert P; Bloch KD; Janssens S
    Circulation; 2007 Aug; 116(8):936-43. PubMed ID: 17679618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitric oxide/soluble guanylyl cyclase signaling mediates depolarization-induced protection of rat mesencephalic dopaminergic neurons from MPP⁺ cytotoxicity.
    Kurauchi Y; Hisatsune A; Isohama Y; Sawa T; Akaike T; Katsuki H
    Neuroscience; 2013 Feb; 231():206-15. PubMed ID: 23238575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. P2Y(1) and P2Y(2) receptors are coupled to the NO/cGMP pathway to vasodilate the rat arterial mesenteric bed.
    Buvinic S; Briones R; Huidobro-Toro JP
    Br J Pharmacol; 2002 Jul; 136(6):847-56. PubMed ID: 12110609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.